NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Neutral

AI Analysis

Summary

NewAmsterdam Pharma announced inducement share option grants totaling 52,900 ordinary shares to five new non-executive hires and one new Vice President, Controller, in compliance with Nasdaq Listing Rule 5635(c)(4).

Importance:1/10

Sentiment:

0.00

inducement grantsequity compensationhiringregulatory compliance

Related Companies

$NAMS

Read the original article

Published by GlobeNewswire Pharma on September 3, 2026 8:01 PM

Read Original